Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries

Autor: Barylnik, Julia, Birdeanu, Laura, Bosch, Gert P, Boychevskaya, Julia, Boyev, Igor, Bugán, Enikõ, Bukhanovskaya, Olga, Chaban, Oleg, Dobrescu, Iuliana, Feller, Gábor, Flisiak-Antonijczuk, Halina, Gácser, Magdolna, Grigorieva, Elena, Holttinen, Timo, Ivanovic-Kovacevic, Svetlana, Kapornai, Krisztina, Kasimova, Lala, Koren, Evgeniy, Martsenkovsky, Igor, Maruta, Nataliya O, Matican, Mirela, Matkovska, Tetiana, Melnyk, Ellina, Milovancevic, Milica Pejovic, Mostova, Olha, Nagy, Peter, Nussbaum, Laura, Petrov, Petar, Pietraszczyk-Kedziora, Bozena, Polnareva, Nadia, Predescu, Elena, Razsolkova, Vladislava, Rybakowski, Filip, Rymsha, Sofiia, Schrönen, Juan P, Shigashov, Dmitrii, Skrypnikov, Andrii, Stankovic, Miodrag, Stevanovic, Dejan, Timonen, Markku, Väänänen, Juha-Matti, van der Westhuizen, Jannie, van Niekerk, Gert, Venger, Olena, Voloshchuk, Anatolii, Wolañczyk, Tomasz, Arango, Celso, Buitelaar, Jan K, Fegert, Jörg M, Olivier, Valérie, Pénélaud, Pierre-François, Marx, Ute, Chimits, Damien, Falissard, Bruno ^*

Publikováno v: In The Lancet Psychiatry February 2022 9(2):113-124